GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Vivos Therapeutics
Vivos Therapeutics produces devices for treating sleep apnea. Its stock price reflects its struggle to commercialize and gain widespread acceptance of its treatment method from doctors and insurance companies.
Share prices of companies in the market segment - Specialized medical equipment
Vivos Therapeutics develops and markets orthodontic devices and treatments for patients with obstructive sleep apnea and breathing disorders. We've classified it as "Specialized Medical Equipment." The chart below shows how the market is evaluating new approaches to treating sleep disorders.
Broad Market Index - GURU.Markets
Vivos Therapeutics is a medical company that offers non-invasive treatments for obstructive sleep apnea using specialized oral appliances. Its unique approach makes it a component of the GURU.Markets index. The chart below compares its performance to the market.
Change in the price of a company, segment, and market as a whole per day
VVOS - Daily change in the company's share price Vivos Therapeutics
Vivos Therapeutics, Inc.'s daily price change reflects volatility in the dental equipment sector. The metric demonstrates sensitivity to demand for its sleep apnea treatment devices, serving as an indicator of innovation.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
Vivos Therapeutics, Inc. is a medical device company. This chart illustrates the high volatility of the MedTech industry. Comparing it to VVOS, which focuses on sleep apnea treatment, helps us understand how its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
Vivos Therapeutics develops devices to treat obstructive sleep apnea. This medtech company's stock price reflects the demand for new solutions to this widespread problem. Its share price reflects the contribution of innovative medicine to overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Vivos Therapeutics
Vivos Therapeutics' year-over-year performance tells the story of its performance in the sleep-disordered breathing market. Its 12-month market cap reflects the success of its oral devices, which offer a non-invasive alternative to CPAP therapy. Regulatory approvals and expanding its network of dentists are key to its growth.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
Vivos Therapeutics, Inc. is a medical device company specializing in the development of devices for the treatment of sleep-disordered breathing. This chart illustrates how its innovative, yet niche, technology and efforts to gain acceptance within the medical community are impacting its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Vivos, with its device for treating sleep apnea, is a growth story in medicine. Its stock price is driven not by the economy, but by its success in commercialization and securing insurance coverage. The chart reflects the potential of a breakthrough technology in a huge market, regardless of the economic climate.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Vivos Therapeutics
Vivos Therapeutics manufactures and markets devices for the treatment of sleep-disordered breathing. Its monthly growth reflects the pace of adoption of its technology by dentists and physicians. Quarterly reports on growth in the number of trained specialists and device sales are the main drivers.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
Vivos Therapeutics offers a non-surgical treatment for sleep apnea using specialized oral devices. The sleep disorder medical device sector is large and growing. The industry dynamics in the graph reflect the overall demand for new solutions. Vivos is seeking to carve out a niche by offering an alternative to traditional CPAP machines.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing treatments for obstructive sleep apnea. Its business depends on physician acceptance of its unique oral devices. The broader market graph serves as a backdrop to assess the market penetration of its non-invasive approach to treating this common condition.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Vivos Therapeutics
Vivos Therapeutics, which develops unique devices for the treatment of obstructive sleep apnea, is extremely sensitive to medical news. Its weekly stock price is a barometer of FDA decisions, the publication of clinical efficacy data, and news of partnerships with dental clinics that expand its reach.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
Vivos Therapeutics, like other medical device manufacturers, is dependent on overall trends in the healthcare sector. However, its focus on sleep apnea treatment makes it sensitive to specific trends in this niche. The chart allows you to compare its performance with the MedTech sector average to highlight this difference.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Vivos Therapeutics, as a biotech company, often ignores broader market trends. Its fate depends not on GDP or inflation, but on FDA decisions and clinical trial data. The chart below clearly demonstrates how Vivos shares can live a life of their own, separate from the broader market.
Market capitalization of the company, segment and market as a whole
VVOS - Market capitalization of the company Vivos Therapeutics
The Vivos Therapeutics chart tells the story of a new approach to sleep apnea treatment. The market cap of this company, which offers specialized oral devices, reflects investors' faith in its alternative to traditional CPAP masks. Its dynamics reflect the market's assessment of the speed of adoption of this technology by doctors and patients.
VVOS - Share of the company's market capitalization Vivos Therapeutics within the market segment - Specialized medical equipment
Vivos Therapeutics offers a patented non-surgical treatment for sleep apnea. Its market share in specialized medical devices reflects recognition of its unique approach to airway management. The graph shows how well its technology competes with traditional methods, such as CPAP machines.
Market capitalization of the market segment - Specialized medical equipment
Vivos Therapeutics offers solutions for sleep apnea treatment using specialized oral devices. The chart below shows the market capitalization of the specialized medical equipment sector. This represents a market seeking new, non-invasive approaches to addressing widespread health issues.
Market capitalization of all companies included in a broad market index - GURU.Markets
Vivos Therapeutics has developed and markets devices to treat sleep apnea by widening the airways. Its market capitalization is a bet on its unique approach to this common problem. The chart below shows the economic weight of companies offering new treatments.
Book value capitalization of the company, segment and market as a whole
VVOS - Book value capitalization of the company Vivos Therapeutics
Vivos Therapeutics is built on a portfolio of medical devices. The company's book value reflects its patents for orthodontic devices for sleep apnea treatment, as well as its inventory of finished products and manufacturing equipment. The chart below shows how the company is building its inventory to advance its unique approach to treating breathing disorders.
VVOS - Share of the company's book capitalization Vivos Therapeutics within the market segment - Specialized medical equipment
Vivos Therapeutics manufactures medical devices for the treatment of sleep apnea, relying on its own manufacturing facilities. This infrastructure is its key tangible asset. The S_BCap_Seg chart shows its share of physical assets in the specialized medical equipment sector.
Market segment balance sheet capitalization - Specialized medical equipment
Vivos Therapeutics produces medical devices for the treatment of sleep-disordered breathing. The development of such devices requires certified manufacturing facilities. The book value chart helps assess how investments in this specialized equipment form the core of its medtech business.
Book value of all companies included in the broad market index - GURU.Markets
Vivos's book value is the production foundation for its healthy sleep technology. The company's assets include manufacturing facilities for patented oral devices and significant inventory of finished products. The chart shows the tangible capital invested in the creation and distribution of a unique medical solution for sleep apnea treatment.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Vivos Therapeutics
Vivos Therapeutics offers solutions for the treatment of sleep apnea. The company's book value reflects its equipment and inventory. Its market capitalization reflects the value of its patented treatment method, its network of trained dentists, and its potential in the vast market of people suffering from sleep apnea.
Market to book capitalization ratio in a market segment - Specialized medical equipment
Vivos Therapeutics offers solutions for the treatment of sleep apnea. The company's value lies in its patented devices and methods. The chart shows the market premium for its innovative approach to this common health problem compared to the book value of its assets, reflecting growth expectations.
Market to book capitalization ratio for the market as a whole
Vivos Therapeutics produces medical devices for the treatment of sleep-disordered breathing. The company's value lies in its patented technology, not just the cost of plastic and electronics. The market sees potential in solving a serious medical problem. The chart illustrates the premium investors are willing to pay for healthcare innovation.
Debts of the company, segment and market as a whole
VVOS - Company debts Vivos Therapeutics
Vivos Therapeutics, a manufacturer of medical devices for the treatment of sleep apnea, is using debt to capture the market. This chart illustrates how the company is funding dental training in its method, as well as investing in patient marketing and manufacturing. It's a strategy where debt accelerates the commercialization and adoption of a new technology.
Market segment debts - Specialized medical equipment
Vivos Therapeutics offers patented devices for the treatment of sleep apnea. Bringing new medical devices to market is a costly process, requiring significant investment in clinical research, marketing, and physician training. This chart illustrates how the company funds its commercial strategy and manages cash flow to achieve market penetration.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Vivos Therapeutics
Vivos Therapeutics offers solutions for the treatment of sleep-disordered breathing. This chart shows the ratio of debt to equity in its financing structure. For a medical company actively promoting its technology, this ratio demonstrates whether it relies on debt to expand its network of partner clinics and for marketing.
Market segment debt to market segment book capitalization - Specialized medical equipment
Vivos Therapeutics offers solutions for sleep apnea treatment, working at the intersection of medicine and technology. This chart for the specialized medical devices sector shows how much capital the industry is raising for clinical research and commercialization. This helps assess how typical the company's financial strategy is for this innovative niche.
Debt to book value of all companies in the market
Vivos Therapeutics combats sleep-disordered breathing by offering non-invasive dental devices. This chart, showing the ratio of debt to book value for the entire market, helps assess how the medical device sector finances its development. For Vivos, which operates at the intersection of medicine and technology, access to debt financing is key to growth.
P/E of the company, segment and market as a whole
P/E - Vivos Therapeutics
Vivos Therapeutics offers devices and treatments for sleep-disordered breathing, particularly obstructive apnea. This chart shows how investors view the potential of its non-invasive approach in the massive market. The high value reflects the belief that more patients and physicians will choose Vivos' solutions over traditional CPAP therapy.
P/E of the market segment - Specialized medical equipment
Vivos Therapeutics is in the specialty medical devices sector. This chart shows the average price-to-earnings ratio (P/E) for this innovative industry. Comparing the company's P/E to this ratio allows one to assess how highly the market values its unique approach to sleep apnea treatment compared to other medical technologies and devices on the market.
P/E of the market as a whole
Vivos Therapeutics offers a non-invasive treatment for obstructive sleep apnea. The company's success depends on the acceptance of its method by the medical community and patients. This chart reflects the overall sentiment in the healthcare sector. It allows one to assess whether the market sees Vivos as a potential revolution in sleep apnea treatment or whether its valuation is moving in line with other speculative medical companies.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Vivos Therapeutics
Vivos Therapeutics offers devices for the treatment of sleep apnea. The chart shows market expectations for future revenue, which depend on the acceptance of their technology by the medical community and the growing number of dentists offering this treatment. Analysts are assessing whether the company can change treatment standards and capture market share from traditional CPAP devices.
Future (projected) P/E of the market segment - Specialized medical equipment
Vivos Therapeutics offers a non-invasive treatment for sleep-related breathing disorders such as apnea using specialized oral devices. This chart shows how its future revenue expectations compare to the industry average. Does the market believe its approach will become a viable alternative to traditional treatments?
Future (projected) P/E of the market as a whole
Vivos Therapeutics offers sleep apnea treatment solutions based on innovative oral appliances. The company's success hinges on the acceptance of its technology by the medical community and approval from insurance companies. This is a story of medical breakthroughs less dependent on general economic cycles.
Profit of the company, segment and market as a whole
Company profit Vivos Therapeutics
Vivos Therapeutics offers a patented solution for treating sleep-disordered breathing, including obstructive sleep apnea. The company's revenue depends on the number of dentists trained and using its system, as well as on insurance company acceptance. This chart shows how the adoption of this innovative approach to sleep apnea treatment impacts financial results.
Profit of companies in the market segment - Specialized medical equipment
Vivos Therapeutics develops and markets specialized medical devices for the treatment of sleep-disordered breathing, specifically obstructive apnea. This chart illustrates the profitability of its niche segment. The company's success depends on the acceptance of its method by doctors and patients. Its commercial results directly shape and largely determine the profitability of this innovative niche.
Overall market profit
Vivos Therapeutics offers an innovative solution for treating sleep apnea. Demand for medical technologies of this kind is determined by their acceptance by the medical community and their accessibility to patients, not by the overall economic climate. The presented corporate earnings chart illustrates the macroeconomic backdrop against which breakthrough medical devices are creating their own markets.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Vivos Therapeutics
Vivos Therapeutics offers solutions for the treatment of sleep-disordered breathing, particularly obstructive apnea. This chart reflects analysts' expectations for future revenue, which depend on the speed of adoption of their technology by dentists and physicians. The rising forecast signals market confidence that Vivos can capture a significant share of the large sleep health market.
Future (predicted) profit of companies in the market segment - Specialized medical equipment
Vivos Therapeutics offers innovative medical devices for the treatment of sleep-disordered breathing, particularly obstructive apnea. This chart shows profitability forecasts for the specialized medical device sector. It illustrates the overall growth expectations for the chronic disease treatment solutions market, in which Vivos occupies a unique niche.
Future (predicted) profit of the market as a whole
Vivos Therapeutics offers solutions for sleep apnea treatment. While health issues require solutions regardless of the economic climate, overall market expectations impact consumer confidence. If a recession is forecast, patients may postpone expensive treatments, which will impact Vivos' growth. The chart below illustrates this macroeconomic backdrop.
P/S of the company, segment and market as a whole
P/S - Vivos Therapeutics
Vivos Therapeutics offers medical devices for the treatment of sleep apnea. The company's revenue depends on the adoption of its technology by dentists and doctors. The P/S for such a medical company reflects investors' belief that its unique treatment approach will become standard and represents a premium for potential sales growth.
P/S market segment - Specialized medical equipment
Vivos Therapeutics offers a non-invasive solution for the treatment of sleep-disordered breathing, including obstructive apnea. Their unique approach could change the standard of care in this field. This chart shows how the market views the commercial potential of their patented technology and future revenue compared to traditional medical device manufacturers.
P/S of the market as a whole
Vivos Therapeutics offers solutions for the treatment of sleep-disordered breathing. The company's revenue depends on the acceptance of its technology by doctors and patients, as well as on insurance payments. This chart illustrates the average revenue estimate, allowing one to assess the market premium for revenue from unique medical devices with growth potential.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Vivos Therapeutics
Vivos Therapeutics offers an innovative solution for treating sleep apnea—specialized oral appliances. The company's success depends on the acceptance of its method by the medical community. This graph reflects investor expectations for future revenue, based on the belief that its technology will become a widely adopted alternative to traditional treatments.
Future (projected) P/S of the market segment - Specialized medical equipment
Vivos Therapeutics offers non-invasive treatments for obstructive sleep apnea using specialized oral devices. This chart shows how the market values the future sales of its unique medical device. It compares it to competitors, reflecting investor confidence in the effectiveness of its technology and growth potential in the sleep disorder treatment market.
Future (projected) P/S of the market as a whole
Vivos Therapeutics offers an innovative solution for treating sleep apnea. The company aims to change the standards in this field of medicine. This chart illustrates general revenue expectations, and Vivos demonstrates how medical startups with breakthrough technologies can create entirely new markets and shape investor expectations for future growth in the healthcare sector.
Sales of the company, segment and market as a whole
Company sales Vivos Therapeutics
Vivos Therapeutics offers an innovative treatment for sleep-disordered breathing, including obstructive apnea. This chart shows revenue from sales of its patented oral appliances and related services to dentists and physicians. Sales growth depends on the expansion of its network of certified providers and patient awareness.
Sales of companies in the market segment - Specialized medical equipment
Vivos Therapeutics offers solutions for the treatment of sleep-disordered breathing. This chart segments the company's revenue, separating revenue from sales of its patented devices and income from dental training programs. This allows one to assess which component of its business model—product or service—contributes more.
Overall market sales
Vivos Therapeutics offers solutions for the treatment of sleep-disordered breathing. Although it's a medical condition, expensive treatment can be perceived as a discretionary expense. This overall economic well-being factor is important to Vivos, as during periods of growth, consumers and healthcare systems are more willing to pay for therapies that improve quality of life.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Vivos Therapeutics
Vivos Therapeutics offers devices and therapies for the treatment of obstructive sleep apnea. The company's revenue forecast depends on the number of dentists and doctors using its method and recognition of its effectiveness. This graph reflects analysts' expectations for the commercialization of its approach to treating this common condition.
Future (projected) sales of companies in the market segment - Specialized medical equipment
Vivos Therapeutics offers an innovative approach to treating sleep-disordered breathing, specifically sleep apnea. This chart shows revenue forecasts for the entire specialized medical devices segment. It reflects growing awareness of sleep disorders and demand for non-invasive treatments, a key market for Vivos' unique oral devices.
Future (projected) sales of the market as a whole
Vivos Therapeutics offers solutions for the treatment of sleep apnea. Demand for its products depends on awareness of the problem and patient affordability. This graph of overall economic expectations reflects the financial health of consumers. Growing confidence allows people to spend more on health care and pay for procedures not always covered by insurance, which is important to Vivos.
Marginality of the company, segment and market as a whole
Company marginality Vivos Therapeutics
Vivos Therapeutics offers solutions for the treatment of sleep-disordered breathing, specifically obstructive apnea. This chart shows the company's success in commercializing its medical devices. Its financial viability depends on expanding its network of certified dentists and receiving reimbursements from insurance companies.
Market segment marginality - Specialized medical equipment
Vivos Therapeutics offers innovative solutions for the treatment of sleep-disordered breathing, such as apnea. The company develops and markets specialized medical devices. This graph shows the average profitability for medical device manufacturers. It allows one to assess the extent to which Vivos's unique technology provides a competitive advantage in profitability.
Market marginality as a whole
Vivos Therapeutics offers solutions for the treatment of sleep-disordered breathing. It's a medical business whose success depends on the acceptance of its technology by doctors and patients, not on general economic cycles. This chart shows the average market profitability, while Vivos strives to create and occupy an entirely new, high-margin niche in healthcare.
Employees in the company, segment and market as a whole
Number of employees in the company Vivos Therapeutics
Vivos Therapeutics offers solutions for the treatment of sleep-disordered breathing. The company's team includes both medical device developers and specialists who train dentists in the use of their methods. The growth in this graph reflects the expansion of the network of certified providers, which is key to scaling the business.
Share of the company's employees Vivos Therapeutics within the market segment - Specialized medical equipment
Vivos Therapeutics offers innovative treatments for sleep-disordered breathing. This chart shows the company's impact on the specialty medical sector through its team. It reflects the percentage of dentists, physicians, and technicians trained and certified to use its unique technology, shaping a new paradigm in sleep apnea treatment.
Number of employees in the market segment - Specialized medical equipment
Vivos Therapeutics offers non-invasive treatments for obstructive sleep apnea. This chart shows employment in the specialized medical equipment niche. The growing number of specialists in this field reflects increased awareness of sleep disorders and demand for innovative, non-surgical solutions, a key market for Vivos.
Number of employees in the market as a whole
Vivos Therapeutics offers solutions for the treatment of sleep-disordered breathing. Growth in the specialized medical equipment sector, where the company operates, indicates increased demand for innovative treatments. The growth trend shown in this chart is partly driven by the expansion of these cutting-edge, science-intensive companies.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Vivos Therapeutics (VVOS)
Vivos Therapeutics offers specialized medical equipment, and its value lies in its unique technology. This chart shows that the market highly values the company's intellectual property and its potential to transform the market. Each employee brings unique knowledge, which is reflected in its high per-capita market capitalization.
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Vivos Therapeutics offers innovative solutions for sleep apnea treatment based on patented devices. In this case, the company's market capitalization per employee is an indicator of the value of its intellectual property. A high value relative to the industry may indicate that the market values the uniqueness and potential of its medical technologies.
Market capitalization per employee (in thousands of dollars) for the overall market
Vivos Therapeutics offers solutions for the treatment of sleep-disordered breathing, specifically obstructive apnea. The company promotes an innovative approach that requires training and certification of dentists. This graph reflects how the market evaluates not only the product itself but also the team's ability to build an educational and partner network for its scalability.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Vivos Therapeutics (VVOS)
Vivos Therapeutics is promoting its technology (oral mouthguards) for treating sleep apnea. Their business is not so much manufacturing as it is training dentists and marketing. During the network building phase, this graph will likely be negative. It shows how much the company is investing in each employee to change the standard of care in this field.
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Vivos Therapeutics combats sleep-disordered breathing with its unique dental devices. This graph illustrates the cost-effectiveness of their approach. It shows how effectively the company generates revenue with its team of specialists, reflecting the value of their intellectual property and the demand for their treatment method compared to other medical solutions.
Profit per employee (in thousands of dollars) for the market as a whole
Vivos Therapeutics offers solutions for the treatment of sleep apnea. The values on this chart show how successfully the company converts its medical innovations into net profit per team member. For Vivos, this is the ratio of expenses on highly qualified R&D specialists and physicians to revenue from sales of patented devices.
Sales to employees of the company, segment and market as a whole
Sales per company employee Vivos Therapeutics (VVOS)
Vivos Therapeutics, a company offering solutions for sleep apnea, demonstrates the effectiveness of its dental training and support model in this graph. Growing revenue per employee indicates that more and more professionals are using Vivos' technology, and the company is successfully scaling its educational and commercial activities.
Sales per employee in the market segment - Specialized medical equipment
Vivos Therapeutics (VVOS) treats sleep-disordered breathing by offering specialized oral appliances (mouth guards). This is a niche medical device segment. This chart shows the average sales per employee in the sector. Comparing Vivos to this figure allows investors to assess how effectively their sales and R&D teams are promoting and monetizing their unique dental solutions compared to competitors.
Sales per employee for the market as a whole
Vivos Therapeutics offers sleep apnea treatment technology by training dentists and selling them specialized devices. This metric reflects the effectiveness of their hybrid business model. It shows how successfully the company is growing sales of its patented devices while leveraging its staff to train and expand its network of dental partners.
Short shares by company, segment and market as a whole
Shares shorted by company Vivos Therapeutics (VVOS)
Vivos Therapeutics is promoting its own system (The Vivos System) for treating sleep apnea—essentially, specialized mouth guards, an alternative to bulky CPAP machines. This chart shows that many investors are skeptical of this technology. The bears are betting that the company will be unable to prove clinical efficacy and convince doctors and insurers that its method is superior to the standard.
Shares shorted by market segment - Specialized medical equipment
Vivos Therapeutics offers innovative mouthguards for the treatment of sleep apnea, often considered a semi-optional procedure. This chart illustrates bearish sentiment in the specialized medical equipment sector. If investors are shorting the industry, they are betting that consumers will save money and postpone expensive, non-urgent medical procedures. For Vivos, this is a sign of weak consumer demand.
Shares shorted by the overall market
Vivos Therapeutics offers devices and therapies to treat sleep apnea, a common but often overlooked condition. This chart measures overall fear. When investors are fearful, they doubt the ability of small companies to reach the market. Vivos needs to convince both doctors and patients, and in an economic downturn, people are reluctant to spend money on less urgent medical solutions.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Vivos Therapeutics (VVOS)
Vivos Therapeutics (VVOS) offers a non-invasive solution for treating sleep apnea. It's a fast-growing market, but the company faces competition. This oscillator measures price momentum. It helps identify when the stock is "overheated" (above 70) due to positive research or "oversold" (below 30) due to investor concerns, signaling a potential reversal.
RSI 14 Market Segment - Specialized medical equipment
Vivos (VVOS) combats sleep apnea not with masks, but with mouthguards. They produce dental devices that alter the structure of the airways. This chart tracks the pulse of the Specialized Medical Equipment sector. It helps distinguish Vivos's unique approach from the generally overhyped or oversold medtech industry.
RSI 14 for the overall market
Vivos (VVOS) is a pure bet on the "future" (sleep apnea treatment). This chart is its lifeline. During periods of market euphoria, investors are willing to generously fund unprofitable but breakthrough R&D projects. In moments of panic, the money supply is turned off, and investors flee speculative ventures.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast VVOS (Vivos Therapeutics)
Vivos Therapeutics (VVOS) offers dentists the Vivos System—customized oral appliances (mouth guards) for the treatment of sleep-disordered breathing, including apnea. This chart shows the average price target from analysts assessing the adoption rate of this system by dentists.
The difference between the consensus estimate and the actual stock price VVOS (Vivos Therapeutics)
Vivos Therapeutics is a medical technology company that has developed a unique mouth guard (the Vivos System) for the non-surgical treatment of sleep apnea (snoring). This chart shows how the current stock price differs from the "fair" value predicted by analysts. It reflects their belief in the potential of this alternative therapy.
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
Vivos Therapeutics (VVOS) is a medical device company offering a non-invasive treatment (the Vivos System mouthguard) for sleep apnea, claiming it addresses the root cause of the problem. This chart shows general expectations for the specialized medical device sector, reflecting whether experts believe in this alternative treatment approach.
Analysts' consensus forecast for the overall market share price
Vivos Therapeutics (VVOS) is a company that "heals while you sleep." They have developed a mouth guard (Vivos System) for the treatment of sleep apnea, which is designed to address the root cause of the problem (the jaw) rather than simply alleviate the symptoms. This chart shows the overall risk appetite, reflecting the market's willingness to fund companies whose breakthrough medical technologies are changing treatment standards.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Vivos Therapeutics
Vivos Therapeutics is a sleep orthodontist. They don't treat symptoms, but sell (through dentists) an oral aligner system (the Vivos System), which they claim restructures the jaw and airway to cure sleep apnea (snoring). This chart summarizes their adoption history, reflecting their (slow) success in convincing dentists and patients of the effectiveness of their regenerative approach.
AKIMA Market Segment Index - Specialized medical equipment
Vivos Therapeutics (VVOS) is a medical technology company specializing in the treatment of obstructive sleep apnea (OSA) in children and adults using its orthodontic appliances (Vivos System). The chart shows the average index for the segment, helping investors assess how successful this non-CPAP alternative is compared to the average.
The AKIM Index for the overall market
Vivos Therapeutics is a medtech company offering non-invasive sleep apnea treatments (oral devices), an alternative to CPAP. This chart, reflecting the market average, is a backdrop. It helps assess how Vivos, which is changing the paradigm of sleep treatment, compares to overall macroeconomic trends.